Search Results for 'Glaucoma'

US pharmaceutical Company, Aerie Pharmaceuticals, Inc. is to establish its first manufacturing plant in Athlone. Aerie is a clinical stage pharmaceutical company focused on the discovery, development and commercialisation of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Aerie Pharmaceuticals establishes state of the art manufacturing facility in Athlone

US Pharmaceutical Company, Aerie Pharmaceuticals, is to establish its first manufacturing plant in Athlone’s Technology & Business Park with an initial investment of €55m. Some 80 jobs will be created at the plant.

US pharmaceutical Company, Aerie Pharmaceuticals, Inc. is to establish its first manufacturing plant in Athlone’s Technology & Business Park. Headquartered in California, with locations in New Jersey, North Carolina, Aerie has also established an Irish entity in Dublin, Aerie Pharmaceuticals Ireland Ltd. Aerie is a clinical stage pharmaceutical company focused on the discovery, development and commercialisation of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

By Five per cent of Galway residents tested positive for age-related macular degeneratio (AMD), a leading cause of blindness, and have since been referred on to an eye specialist.

This year’s AMD Awareness Week is running from September 22 to 30, to promote early detection of the signs of AMD (Age-related Macular Degeneration), the most common cause of registered blindness in Ireland.  AMD is the principal cause of sight loss for people over the age of 50 in the western world and, although it is not as well known as other eye diseases such as cataracts or glaucoma, it is thought to affect one in 10 Irish people over the age of 50. 

This year’s AMD Awareness Week is running from September 22-30 to promote early detection of the signs of AMD (age-related macular degeneration), the most common cause of registered blindness in Ireland.

Ford has joined forces with Cambridge University to gain a better understanding of visual impairment issues that come with an aging society and to use digital tools to better design vehicles for those with vision problems.

Most people are aware of the importance of an eye examination every two years for the purposes of their sight. Many, however, overlook the emphasis your optician places on your eye health. Previously an ophthalmoscope alone was used to look at the back of the eye, but this is now used in addition to a new technology called the fundus camera.

People over the age of 40 could be risking their eyesight as they may be unaware they have glaucoma, the second largest cause of unnecessary blindness.